The global amniotic membrane market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections.

The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion. The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery.

Further key findings from the study suggest:

Cryopreserved is expected to be the dominant segment in future as it’s highly effective and ensures preservation of histological and biological properties

Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications

Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed

North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases

The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries